Drugs, Ethics, and Quality of Life Cases and Materials on Ethical, Legal, and Public Policy Dilemmas in Medicine and Pharmacy Practice

• Foreword (Kenneth V. Iserson)
• Preface
• Acknowledgments
• Introduction: Pellegrino on Professionalism: A Human Values Basis for the Healing Arts
• Appendix: Principles of Medical Ethics of the American Medical Association (2001)
• Special Additional Introduction: Ethics and a Code of Ethics in Pharmacy Practice (Joseph L. Fink III)
• Appendix: Code of Ethics for Pharmacists of the American Pharmacists Association (1994)
• PART I: FOUNDATIONAL BASICS
• Chapter 1. Tobacco and Choices: How Values and Definitions Impact Decision Making
• FDA’s 1996 Tobacco Regulations and FDA v. Brown & Williamson
• Definitions
• Continuing Dilemmas with Tobacco
• Chapter 2. COX-2 Inhibitors and Conflict: How Balancing Beneficence and Nonmaleficence Influences Decision Making
• COX-2 Inhibitors and Their Effects
• The FDA’s Drug Approval Process and VIOXX
• A Balancing Act: Beneficence, Nonmaleficence, and Profit and Other Motives
• Cost-Benefit Analysis, Stakeholders, and Issues Management Analysis
• Continuing Dilemmas with COX-2 Inhibitors
• Chapter 3. Marijuana, Individual Liberty, and Police Power: How Autonomy Drives Decision Making
• Marijuana
• Marijuana Control in the United States
• Personal Freedom, Autonomy, and the California Compassionate Use Act
• State Police Power and Federalism: Gonzales v. Raich
• Continuing Dilemmas with Medical Marijuana
• Appendix: Examples of California’s Criminal Statutes Controlling Marijuana Calif. Health & Safety Code §§ 11357 and 11358
• Chapter 4. The “Morning-After” Pill and Systematic Ethics and Public Policy Analysis: How Justice Tempers Decision Making
• Emergency Contraceptives and Rights
• Balancing “Rights”: Ethics and Public Policy
• Justice and Conscientious Objection
• Conflict and Systematic Ethical Analysis
• Continuing Dilemmas with Emergency Contraceptives
• PART II: PAIN MEDICINES AND END-OF-LIFE DRUGS
• Chapter 5. Pain Medicines and Palliative Care Drugs
• Bergman v. Chin
• When Will Adequate Pain Control Be the Norm?
• Continuing Dilemmas with Pain Medicines and Palliative Care Drugs
• Chapter 6. Drugs Used for Assisted Suicide
• The Debate about Physician-Assisted Suicide and Euthanasia
• The Oregon Death with Dignity Act
• Continuing Dilemmas with Assisted Suicide and Euthanasia
• Chapter 7. Drug Use in “Dwindling” Patients and in Medically Futile Situations
• “Dwindling” Patients and Quality of Life
• Medical Futility
• Surrogate Medical Decision Making
• Continuing Dilemmas Involving Drug Use in “Dwindling” Patients and Medically Futile Situations
• Appendix: Tennessee Health Care Decisions Act (2004)
• PART III: DRUG EXPERIMENTATION
• Chapter 8. Gene Therapy and Experimentation
• The Federal Drug Research and Patient Safety Framework
• Gelsinger v. University of Pennsylvania
• Continuing Dilemmas with Gene Therapy and Experimentation
• Afterword (John Lachs)
• Appendix 1. Law and Decisions
• Objectives
• What Does Law Mean?
• What Are the Four Primary Sources of Law in the United States?
• How Do the People (The Nation’s Citizens) Create Law?
• How Do Legislative Bodies Create Law?
• How Do Federal and State Administrative Agencies Create Law?
• How Do Federal and State Judges Create Law?
• Appendix 2. Continuing Dilemmas Involving Drugs, Ethics, and Quality of Life: An Outline for Further Discussion
• Topics Related to Drug Use
• Topics Related to Professional Virtues
• Notes
• Index

Biography

Bruce D. White